SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bittensor (TAO) is a cryptocurrency launched in 2021and operates on the Bittensor platform. Bittensor has a current supply of 21,000,000 with 11,727,911.30015715 in circulation. The last known price of Bittensor is 182.74993229 USD and is down -15.42 over the last 24 hours. It is currently trading on 339 active market(s) with $220,769,283.80 traded over the last 24 hours. More information can be found at https://bittensor.com.

Bittensor

TAO is under pressure alongside broader crypto-market weakness, with traders pointing to Bitcoin selling pressure and debating whether the decline is a buying opportunity or a sign of further downside. Many are accumulating on weakness based on Bittensors decentralized-AI and subnet-growth thesis, while skeptics question whether adoption and revenue are strong enough to support the tokens value.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,112,050. The last known price of Bitcoin is 63,437.21016941 USD and is down -7.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $45,086,253,428.50 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and volatile rebound have traders debating whether heavy liquidations and oversold conditions mark a capitulation low or a pause in a continuing downtrend. Some see dip-buying and a potential short squeeze, while others expect further declines and warn that the bounce may be temporary.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyvernas completed rolling BLA submission for miv-cel in stiff person syndrome, with a request for priority review, is the main focus as traders await FDA acceptance. Some see the filing as a key step toward approval, while others point to the stocks weak reaction, cash burn and remaining regulatory uncertainty.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRSP is under pressure near 52-week lows despite traders highlighting rising CASGEVY uptake; discussion centers on whether the commercial ramp can offset frustration with the share-price decline and concerns about pipeline execution and management. Some investors view the weakness as a disconnect from business progress, while others see little evidence of near-term value creation.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingos Q3 report sparked a sharp rally as accelerating daily-user growth, revenue strength and a raised full-year outlook outweighed an earnings-per-share miss. Traders are debating whether the move can hold, with bullish short-squeeze and growth arguments facing concerns about valuation, monetization and AI competition.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,218,624.4003947. The last known price of Ethereum is 1,739.90377069 USD and is down -9.84 over the last 24 hours. It is currently trading on 14359 active market(s) with $18,820,901,710.98 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is being discussed amid a sharp crypto-wide selloff, with traders pointing to Bitcoin weakness, leveraged long liquidations and thin buying interest. The community is split between calling the decline capitulation and a buying opportunity versus warning of further downside, with some attributing the pressure to broader risk-off sentiment and tech-market weakness.

Internet Computer (ICP) is a cryptocurrency launched in 2021. Internet Computer has a current supply of 558,959,322.05396567. The last known price of Internet Computer is 2.1459041 USD and is down -13.18 over the last 24 hours. It is currently trading on 448 active market(s) with $76,241,162.22 traded over the last 24 hours. More information can be found at https://internetcomputer.org/.

Internet Computer

ICPs decline amid broad crypto-market weakness is fueling debate over DFINITYs Cloud Engines rollout, which bulls view as a potential decentralized-cloud growth driver. Skeptics argue the technology still needs to show real adoption, customers and token demand, while holders point to its longer-term AI and infrastructure potential.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 0.92173784 USD and is down -8.73 over the last 24 hours. It is currently trading on 1896 active market(s) with $4,059,642,828.82 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is drawing attention amid a sharp, broad crypto selloff that traders largely link to Bitcoin weakness and leveraged-position liquidations. The community is split between calling the decline a buying opportunity and warning that continued losses, token supply concerns, and doubts about XRPs utility could prolong the downturn.

Avalanche (AVAX) is a cryptocurrency launched in 2020. Avalanche has a current supply of 471,438,169.1160568 with 446,436,169.1160568 in circulation. The last known price of Avalanche is 6.99518175 USD and is down -15.00 over the last 24 hours. It is currently trading on 1135 active market(s) with $402,139,637.32 traded over the last 24 hours. More information can be found at https://avax.network/.

Avalanche

AVAX is drawing attention for a sharp selloff amid weak crypto sentiment, with traders repeatedly tying its moves to Bitcoin and saying it has lagged recoveries across the market. The community is split between dip buyers and frustrated holders, with some arguing that institutional tokenization headlinesincluding the NYSE selectionhave not translated into lasting token gains.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,079,921,637.950731 in circulation. The last known price of Algorand is 0.07697008 USD and is down -9.60 over the last 24 hours. It is currently trading on 586 active market(s) with $68,192,697.70 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

ALGOs retreat toward recent lows has intensified debate over whether support is forming or the decline will continue. Bulls describe a possible bottom and say they are accumulating, while bears warn that support may fail and see further downside; no single reversal view is shared.

statis crypto Watchlist

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is GEV Stock Drawing Investor Attention Today?

Equity

GE Vernova now expects 2026 revenue of $44–$45 billion, up from $41–$42 billion, and lifted its 2028 revenue target to $56 billion from $52 billion.

Themes ETF Trust - Leverage Shares 2X Long GEV Daily ETF

Neutral Sentiment

<ul class="summary-bullets"><li>For Q4 2025, GE Vernova reported a better-than-expected revenue of $10.96 billion</li><li>Net income came in at $3.7 billion, supported by a $2.9 billion tax benefit.</li><li>China Renaissance initiated stock coverage with a ‘Buy’ rating and a price target of $966.</li></ul>GE Vernova (GEV) on Wednesday raised its full-year 2026 and 2028 revenue guidance, following regulatory approval for the acquisition of Prolec GE, which is expected to close on Feb. 2, 2026.For FY 2026, the company now forecasts revenue of $44 billion to $45 billion, up from $41 billion to $42 billion, with an adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin of 11% to 13%.&nbsp;Segment-wise, Power is expected to deliver 16% to 18% organic revenue growth with margins of 16% to 18%. Wind revenue is projected to decline at a low double-digit rate, with an EBITDA loss of around $400 million, while Electrification revenue is seen at $13.5 billion to $14 billion, including roughly $3 billion from Prolec GE.Looking ahead to FY2028, the company now targets $56 billion in revenue, up from the $52 billion it had forecast earlier.<h2 class="st-heading-2">Q4 Results</h2>For Q4 2025, GE Vernova reported revenue of $10.96 billion, up 4%, and above Wall Street estimates of $10.22 billion, according to Fiscal.ai data. Net income came in at $3.7 billion, supported by a $2.9 billion tax benefit. &nbsp;The company also declared a quarterly dividend of $0.50 per share.<a href="https://stocktwits.com/symbol/GEV">GEV stock</a> was down nearly 3% in pre-market trading but climbed marginally higher after the opening bell.“Given our strong free cash flow generation, we ended the quarter with a healthy cash balance of nearly $9 billion, which continues to give us confidence to invest in our core businesses and return cash to shareholders through our share repurchase actions and quarterly dividend payment, while maintaining a strong investment grade balance sheet,” said&nbsp;GE Vernova CFO&nbsp;Ken Parks.&nbsp;Separately, China Renaissance initiated coverage of GE Vernova with a ‘Buy’ rating and a price target of $966.<h2 class="st-heading-2">Retail Reaction</h2>Retail sentiment on Stocktwits flipped to ‘extremely bullish’ from ‘neutral,’ amid ‘extremely high’ message volumes.One user spoke about the stock’s steady upside move.<stembedurl>https://stocktwits.com/terrin07/message/643149766</stembedurl>One user speculated on why the stock's movement didn’t align with the overall earnings.<stembedurl>https://stocktwits.com/Mahvalousday/message/643119968</stembedurl>The stock has gained over 97% in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the GE Vernova company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

GE Vernova Inc.

Leverage Shares 2x Long GEV Daily ETF

Tradr 2X Long GEV Daily ETF

Vanguard Total Stock Market ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

About GEVG